MRNA
Valuation Healthcare · Biotechnology Data as of 2026-03-31P/E Ratio · Metrics
P/E Ratio
-
PEG Ratio
-
Dividend Yield
-
Gross Margin
-145.50%
Net Margin
-345.24%
Revenue CAGR 3Y
-40.41%
ROE
-72.52%
ROA
-46.76%
Buyback Yield
-0.77%
Current Ratio
2.41
Magic Earn Yield
-28.54%
Altman Z-Score
3.66
Fair Value River
Score
Valuation 0
Profitability 0
Growth 0
Health 77
Yield 0